Arca
Skip to content
Tools
Tools

-one

Chemicals with a ketone group.

  • Drugs ending in -one: 115
  • Approved somewhere: 38
  • With a US drug page: 33

What it means

Stem from WHO's stem book, 2024; description by Arca
Stem
-one
Class
Chemicals with a ketone group
Most common targets
HTR2A (5), NR3C1 (4), Tubulin (4), DRD2 (3), OPRM1 (3), SLC6A4 (3), HTR2C (3), PGR (3)

Drugs that carry it

Approved and clinical-stage drugs in ChEMBL whose names ending in -one, matched by spelling; those with a US drug page link to it.
Acts on
AtovaquoneApprovedMT-CYBCytochrome b inhibitor
ChlorthalidoneApprovedSLC12A3Thiazide-sensitive sodium-chloride cotransporter inhibitor
DapsoneApprovedFOLP1Dihydropteroate synthase 1 inhibitor
DeferiproneApproved—Unknown
Diflorasone diacetateApprovedNR3C1Glucocorticoid receptor agonist
EdaravoneApproved—Unknown
Fluticasone furoateApprovedNR3C1Glucocorticoid receptor agonist
Fluticasone propionateApprovedNR3C1Glucocorticoid receptor agonist
IxabepiloneApprovedTubulinTubulin inhibitor
LurasidoneApprovedHTR2A, DRD2Serotonin 2a (5-HT2a) receptor antagonist
MedrysoneApprovedNR3C1Glucocorticoid receptor agonist
MenadioneApproved——
MethadoneApprovedOPRM1Mu opioid receptor agonist
MethylnaltrexoneApprovedOPRM1Mu opioid receptor antagonist
MolindoneApprovedDRD2, HTR2ADopamine D2 receptor antagonist
NefazodoneApprovedSLC6A4, HTR2A, HTR2C, SLC6A2Serotonin transporter inhibitor
ParamethadioneApprovedVoltage-gated T-type calcium channelVoltage-gated T-type calcium channel blocker
PhenindioneApprovedVKORC1Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor
PhytonadioneApproved——
PirfenidoneApproved—Unknown
PrimidoneApprovedGABA-A receptor; anion channel, Sodium channel alpha subunitGABA-A receptor; anion channel positive allosteric modulator
SpironolactoneApprovedNR3C2Mineralocorticoid receptor antagonist
SulfoxoneApprovedFOLP1Dihydropteroate synthase 1 inhibitor
TrazodoneApprovedSLC6A4, HTR2A, HTR2CSerotonin transporter inhibitor
TrimethadioneApprovedVoltage-gated T-type calcium channelVoltage-gated T-type calcium channel blocker
VilazodoneApprovedSLC6A4, HTR1ASerotonin transporter inhibitor
DordavipronePhase 3—Unknown
MetyraponePhase 3CYP11B1Cytochrome P450 11B1, mitochondrial inhibitor
TestolactonePhase 2CYP19A1Cytochrome P450 19A1 inhibitor
Anisindione—GGCXVitamin K-dependent gamma-carboxylase inhibitor
Chlormezanone——Unknown
Furazolidone—DNADNA inhibitor
Metaxalone——Unknown
AcetarsoneApproved—Unknown
BenzhydrocodoneApprovedOpioid receptors; mu/kappa/deltaOpioid receptors; mu/kappa/delta agonist
DimethiconeApproved—Unknown
EnoximoneApprovedPDE3A, PDE3BPhosphodiesterase 3 inhibitor
FluindioneApproved——
HydrocodoneApprovedOpioid receptors; mu/kappa/deltaOpioid receptors; mu/kappa/delta agonist
HydroquinoneApproved——
IdebenoneApproved—Antioxidant and mitochondrial electron carrier
Norethindrone acetateApprovedPGRProgesterone receptor agonist
OxycodoneApprovedOPRM1Mu opioid receptor agonist
ToloxatoneApprovedMAOAMonoamine oxidase A inhibitor
ZiprasidoneApprovedHTR2A, HTR2C, DRD2Serotonin 2a (5-HT2a) receptor antagonist
ApabetalonePhase 3Bromodomain and extra-terminal motif (BET)Bromodomain and extra-terminal motif (BET) inhibitor
ApaziquonePhase 3DNADNA inhibitor
Clobetasone butyratePhase 3—Unknown
EperisonePhase 3——
EsmethadonePhase 3——
FluticasonePhase 3——
GlutathionePhase 3——
HydronidonePhase 3——
IsoflavonePhase 3——
NibrozetonePhase 3——
NorethindronePhase 3PGRProgesterone receptor agonist
OxiglutationePhase 3GSRGlutathione reductase other
PatupilonePhase 3TubulinTubulin stabiliser
PovidonePhase 3——
RecoflavonePhase 3——
SimethiconePhase 3—Antifoaming agent
SimeticonePhase 3—Anti-gas, surfactant
ThiazolidinedionePhase 3——
TolperisonePhase 3——
VatiquinonePhase 3NQO1Quinone reductase 1 modulator
AdrenalonePhase 2——
Bone morphogenetic protein 2Phase 2——
CarboquonePhase 2——
ClorindionePhase 2——
DifetarsonePhase 2——
DiphenadionePhase 2——
Epothilone dPhase 2TubulinTubulin stabiliser
FlavonePhase 2——
FluanisonePhase 2——
FlumedroxonePhase 2——
HalofuginonePhase 2——
HymecromonePhase 2——
IpriflavonePhase 2——
IsobromindionePhase 2——
ItruvonePhase 2——
KetobemidonePhase 2——
LapachonePhase 2——
LevomethadonePhase 2——
LucanthonePhase 2——
MacozinonePhase 2DPRE1FAD-dependent decaprenylphosphoryl-beta-D-ribofuranose 2-oxidase inhibitor
Menaquinone 6Phase 2——
MephenoxalonePhase 2——
MethylonePhase 2——
MorclofonePhase 2——
NapazimonePhase 2——
NepinalonePhase 2——
NizofenonePhase 2——
NormethadonePhase 2——
OxetoronePhase 2——
PhanquonePhase 2——
SagopilonePhase 2TubulinTubulin stabiliser
Tanshinone iia sulfonic acidPhase 2——
TerizidonePhase 2——
ThymoquinonePhase 2——
TiloronePhase 2——
TolimidonePhase 2LYNTyrosine-protein kinase Lyn positive allosteric modulator
TrepibutonePhase 2——
TriaziquonePhase 2——
DaniquidonePhase 1——
DiphencypronePhase 1——
MephedronePhase 1——
MethylpyrrolidonePhase 1——
OchromycinonePhase 1——
Chlormadinone acetate—PGRProgesterone receptor modulator
Ethadione———
Exifone——Unknown
Methaqualone—GABA-A receptor; anion channelGABA-A receptor; anion channel positive allosteric modulator
Piperidione———
Pyrithione——Unknown
Pyrovalerone—SLC6A2, SLC6A3Monoamine transporters; Norepinephrine & dopamine inhibitor

Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.